Laurie Toich, Assistant Editor

Altered flora from antibiotics could affect future drug response and susceptibility to side effects.

MCL-1 inhibitor drug class could potentially cure the bone marrow cancer.

Non-Hispanic blacks less likely to receive opioids for non-definitive conditions such as a toothache.

HIV-positive men were more likely to have increased levels of inflammatory biomarkers than HIV-negative men.

Top news of the day from across the healthcare landscape.

The database compiles proteins involved with autophagy.

Bacterial differences were seen between tissue from patients with and without breast cancer.

A patent for a rheumatoid arthritis drug was ruled invalid, but Johnson & Johnson plans to appeal the decision.

Esketamine could treat major depressive disorder with an imminent suicide risk.

New system allows direct absorption of a drug and prevents first past metabolism.

Only 1 patient died from not receiving carcinoma treatment, while 21 patients who received treatment died.

Top news of the day from across the healthcare landscape.

New imaging technique could allow physicians to see if an anti-depressant is effective in a patient.

Researchers plan to create an extensive cancer screening test that detects cancer blood biomarkers.

Aetna hopeful for a better exchange model to help uninsured individuals.

The state has enrolled more than 278,000 people in Healthy Louisiana since July 1.

Many states have started charging drug dealers with the deaths of their customers if they sold them their final dose of opioids.

New study aims to create evidence-based personalized treatments for patients with bipolar disorder.

The prescription drug epidemic could potentially be a widespread problem.

Patients with a high body mass index showed decreased white matter volume, suggesting brain age-related brain shrinkage.

Top news of the day from across the healthcare landscape.

Through physical evaluation, biphenotypic primary liver carcinoma could be misclassified.

A speedy approval process could be implemented through using a large amount of unused fees from pharmaceutical manufacturers.

The company will conduct a non-small cell lung cancer clinical trial with CV301 plus Opdivo.

Antiepileptic treatment was most likely to affect women and patients with temporal lobe epilepsy.

Testing before prescribing antibiotics could prevent antibiotic resistance.

Top news of the day from across the healthcare landscape.

Multiple medications that target G protein coupled receptors could prevent disease-related visual impairment.

Coordinating care between emergency services and hospitals could reduce fatalities from ST-segment elevation myocardial infarction.

Researchers found single-nucleotide polymorphisms in multiple cell types.